No Data
No Data
Theratechnologies Shares Are Trading Higher After the Company Announced It Has Resumed the Distribution of EGRIFTA.
Theratechnologies | 6-K: Report of foreign private issuer (related to financial reporting)
Research Capital Maintains Theratechnologies(THTX.US) With Buy Rating
Theratechnologies Upgraded to Buy From Speculative Buy at Mackie Research
Theratechnologies to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update
Reported Earlier, Theratechnologies Resumes Distribution Of EGRIFTA SV As FDA Clears Two Newly Manufactured Batches
Unlock the Full List